Submitted by Anonymous (not verified) on 11 October 2024 - 15:39
Human medicines European public assessment report (EPAR): Halaven, eribulin, Date of authorisation: 17/03/2011, Revision: 31, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Halaven, eribulin, Date of authorisation: 17/03/2011, Revision: 31, Status: Authorised